HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skin Care Carries J&J Consumer Biz. In Quarter Marred By OTC Drug Recall

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson's skin-care franchise helped offset weak oral-care sales and hampered over-the-counter and nutritionals business associated with a recall of Motrin, Tylenol and other products in the firm's fiscal 2010 first quarter

You may also be interested in...



FDA Flags J&J For Inadequate Oversight Of Consumer Devices

Though the firm claims to have come a long way in improving management of OTC pharma quality control since its 2009/2010 recalls, a May 22 warning letter regarding post-market monitoring and pre-market notifications for K-Y moisturizers suggests consumer devices are not getting the same level of attention.

J&J Extends Leading Skin-Care Brands With Kits Featuring Cytomimic

Capitalizing on momentum in its skin-care business, Johnson & Johnson is introducing new Cytomimic technology to its Aveeno, Neutrogena and RoC brands with dual-product kits for anti-aging needs around the clock

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS016891

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel